These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 25063723)

  • 1. Central nervous system complications of varicella-zoster virus.
    Science M; MacGregor D; Richardson SE; Mahant S; Tran D; Bitnun A
    J Pediatr; 2014 Oct; 165(4):779-85. PubMed ID: 25063723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safety profile of varicella vaccine: a 10-year review.
    Galea SA; Sweet A; Beninger P; Steinberg SP; Larussa PS; Gershon AA; Sharrar RG
    J Infect Dis; 2008 Mar; 197 Suppl 2():S165-9. PubMed ID: 18419392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Varicella-zoster virus CNS disease--viral load, clinical manifestations and sequels.
    Persson A; Bergström T; Lindh M; Namvar L; Studahl M
    J Clin Virol; 2009 Nov; 46(3):249-53. PubMed ID: 19709927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymerase chain reaction for diagnosis of varicella zoster virus central nervous system infections without skin manifestations.
    Bergström T
    Scand J Infect Dis Suppl; 1996; 100():41-5. PubMed ID: 9163024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Varicella-zoster virus infection in Romanian children infected with the human immunodeficiency virus.
    Leibovitz E; Cooper D; Giurgiutiu D; Coman G; Straus I; Orlow SJ; Lawrence R
    Pediatrics; 1993 Dec; 92(6):838-42. PubMed ID: 7901834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical course and therapeutic approach to varicella zoster virus infection in children with rheumatic autoimmune diseases under immunosuppression.
    Leuvenink R; Aeschlimann F; Baer W; Berthet G; Cannizzaro E; Hofer M; Kaiser D; Schroeder S; Heininger U; Woerner A
    Pediatr Rheumatol Online J; 2016 Jun; 14(1):34. PubMed ID: 27256096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid molecular discrimination between infection with wild-type varicella-zoster virus and varicella vaccine virus.
    Lässker U; Harder TC; Hufnagel M; Suttorp M
    Infection; 2002 Oct; 30(5):320-2. PubMed ID: 12382096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infection of the central nervous system caused by varicella zoster virus reactivation: a retrospective case series study.
    Becerra JC; Sieber R; Martinetti G; Costa ST; Meylan P; Bernasconi E
    Int J Infect Dis; 2013 Jul; 17(7):e529-34. PubMed ID: 23566589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herpes zoster and meningitis due to reactivation of varicella vaccine virus in an immunocompetent child.
    Han JY; Hanson DC; Way SS
    Pediatr Infect Dis J; 2011 Mar; 30(3):266-8. PubMed ID: 20844461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neurological complications of varicella-zoster virus (VZV) infection].
    Shiihara H
    No To Hattatsu; 1993 Mar; 25(2):128-34. PubMed ID: 8461162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Varicella-zoster virus (VZV) DNA in serum of patients with VZV central nervous system infections.
    Grahn A; Bergström T; Runesson J; Studahl M
    J Infect; 2016 Sep; 73(3):254-60. PubMed ID: 27317379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Varicella zoster virus associated acute aseptic meningitis without exanthem in an immunocompetent 14-year-old boy.
    Leahy TR; Webb DW; Hoey H; Butler KM
    Pediatr Infect Dis J; 2008 Apr; 27(4):362-3. PubMed ID: 18316987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary varicella zoster infection compared to varicella vaccine reactivation associated meningitis in immunocompetent children.
    Amaral V; Shi JZ; Tsang AM; Chiu SS
    J Paediatr Child Health; 2021 Jan; 57(1):19-25. PubMed ID: 33295075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe complications of varicella in previously healthy children in Germany: a 1-year survey.
    Ziebold C; von Kries R; Lang R; Weigl J; Schmitt HJ
    Pediatrics; 2001 Nov; 108(5):E79. PubMed ID: 11694663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety profile of live varicella virus vaccine (Oka/Merck): five-year results of the European Varicella Zoster Virus Identification Program (EU VZVIP).
    Goulleret N; Mauvisseau E; Essevaz-Roulet M; Quinlivan M; Breuer J
    Vaccine; 2010 Aug; 28(36):5878-82. PubMed ID: 20600487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute cerebellar ataxia in the Netherlands: a study on the association with vaccinations and varicella zoster infection.
    van der Maas NA; Bondt PE; de Melker H; Kemmeren JM
    Vaccine; 2009 Mar; 27(13):1970-3. PubMed ID: 19186201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterisation of varicella-zoster virus strains in Germany and differentiation from the Oka vaccine strain.
    Sauerbrei A; Eichhorn U; Gawellek S; Egerer R; Schacke M; Wutzler P
    J Med Virol; 2003 Oct; 71(2):313-9. PubMed ID: 12938208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Varicella-zoster virus: a re-emerging infection.
    LaGuardia JJ; Gilden DH
    J Investig Dermatol Symp Proc; 2001 Dec; 6(3):183-7. PubMed ID: 11924825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of a two-dose regime of varicella vaccine in children with cancers.
    Leung TF; Li CK; Hung EC; Chan PK; Mo CW; Wong RP; Chik KW
    Eur J Haematol; 2004 May; 72(5):353-7. PubMed ID: 15059071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic value of VZV PCR in cerebrospinal fluid in neurological manifestations of varicella].
    Levy M; Hentgen V; Marque-Juillet S; Fiot E; Fagherazzi G; Nathanson S; Foucaud P
    Arch Pediatr; 2015 May; 22(5):491-7. PubMed ID: 25819633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.